5 Results for "

TPA-induced EBV-EA activation

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "TPA-induced EBV-EA activation" in MCE Product Catalog:

Cat. No.: HY-N11020
CAS No.: 88901-40-0
Cabenoside D (compound 8) is a triterpenoid glycoside, which can be isolated from the methanol extract of lichen root. Cabenoside D shows anti-inflammatory activity and inhibits inflammation induced by 12-O-tetracylacyl hormone-13-acetate (TPA) in mice. Cabenoside D also inhibits TPA-induced Epstein-Barr virus (EBV) early antigen (EBV-EA) activation .
loading...
    loading...
Cat. No.: HY-N17354
CAS No.: 28333-13-3
Glycocitrine II is an acridone alkaloid. Glycocitrine II can be isolated from the Rutaceous plants. Glycocitrine II inhibits 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced EBV-EA activation .
loading...
    loading...
Cat. No.: HY-N13723
CAS No.: 98665-09-9
Methyl lucidenate D is a selective inhibitor of Epstein-Barr virus early antigen (EBV-EA) activation with an IC50 of 290 mol ratio/32 pmol TPA. Methyl lucidenate D exerts potential anti-tumor promoting activity by inhibiting TPA-induced EBV-EA activation and maintains major Raji cell survival (70%) at effective concentrations. Methyl lucidenate D can be used in the field of cancer chemoprevention .
loading...
    loading...
Cat. No.: HY-N19721
CAS No.: 514214-46-1
Brasimarin B is a 4-phenylcoumarin compound found in the stem bark of Calophyllum brasiliense. Brasimarin B inhibits TPA (HY-18739)-induced EBV-EA activation in Raji cells .
loading...
    loading...
loading...
    loading...